Skip to main content

Advertisement

Fig. 10 | Malaria Journal

Fig. 10

From: Prioritization of anti-malarial hits from nature: chemo-informatic profiling of natural products with in vitro antiplasmodial activities and currently registered anti-malarial drugs

Fig. 10

Toxicity profile of currently registered anti-malarial drugs and natural products with in vitro antiplasmodial activities. The upper panel a is for the CRAD while the lower panel b is for NAA. Three indicators were used to assess the toxicity: tumourigenic, irritant and mutagenic. A greater proportion of NAA were predicted to have low risk of the toxicity indicators assessed

Back to article page